A study to investigate the efficacy and safety of fitusiran prophylaxis in male participants aged 1 to less than 12 years with hemophilia A or B

Trial Identifier: EFC17905
Sponsor: Sanofi
Start Date: December 2025
Primary Completion Date: August 2029
Study Completion Date: December 2031
Condition: Hemophilia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CANADA, Quebec Montreal, Quebec, CANADA, H3T 1C5
SPAIN, Barcelona [Barcelona] Esplugues De Llobregat, Barcelona [Barcelona], SPAIN, 08950
SPAIN, Madrid Madrid, SPAIN, 28046
SPAIN, Zaragoza Zaragoza, SPAIN, 50009
Turkey Istanbul, Turkey, 34093
Turkey Izmir, Turkey, 35100
UNITED STATES, California Los Angeles, California, UNITED STATES, 90007
UNITED STATES, California Orange, California, UNITED STATES, 92868